-
1
-
-
84866368808
-
ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction
-
a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2012;60:645-81.
-
Jneid H, Anderson JL, Wright RS, Adams CD, Bridges CR, Casey Jr DE, et al. ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2012;60:645-81.
-
(2007)
Updating the 2007 Guideline and Replacing the 2011 Focused Update
-
-
Jneid, H.1
Anderson, J.L.2
Wright, R.S.3
Adams, C.D.4
Bridges, C.R.5
De, C.J.6
-
2
-
-
84886946711
-
Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapy
-
23978596
-
Tanguay JF, Bell AD, Ackman ML, Bauer RD, Cartier R, Chan WS, et al. Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapy. Can J Cardiol. 2013;29:1334-45.
-
(2013)
Can J Cardiol
, vol.29
, pp. 1334-1345
-
-
Tanguay, J.F.1
Bell, A.D.2
Ackman, M.L.3
Bauer, R.D.4
Cartier, R.5
Chan, W.S.6
-
3
-
-
0035899289
-
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
-
1:CAS:528:DC%2BD3MXms1arsrY%3D 11519503
-
Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494-502.
-
(2001)
N Engl J Med
, vol.345
, pp. 494-502
-
-
Yusuf, S.1
Zhao, F.2
Mehta, S.R.3
Chrolavicius, S.4
Tognoni, G.5
Fox, K.K.6
-
4
-
-
36148983750
-
Prasugrel versus clopidogrel in patients with acute coronary syndromes
-
1:CAS:528:DC%2BD2sXhtlWis7rN 17982182
-
Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357:2001-15.
-
(2007)
N Engl J Med
, vol.357
, pp. 2001-2015
-
-
Wiviott, S.D.1
Braunwald, E.2
McCabe, C.H.3
Montalescot, G.4
Ruzyllo, W.5
Gottlieb, S.6
-
5
-
-
70149101223
-
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
-
1:CAS:528:DC%2BD1MXhtFaltL%2FJ 19717846
-
Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361:1045-57.
-
(2009)
N Engl J Med
, vol.361
, pp. 1045-1057
-
-
Wallentin, L.1
Becker, R.C.2
Budaj, A.3
Cannon, C.P.4
Emanuelsson, H.5
Held, C.6
-
6
-
-
73649128574
-
Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: A position statement of the Canadian Cardiovascular Society
-
2807829 1:CAS:528:DC%2BC3cXktlWgug%3D%3D 19960127
-
Fitchett D, Eikelboom J, Fremes S, Mazer D, Singh S, Bittira B, et al. Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: a position statement of the Canadian Cardiovascular Society. Can J Cardiol. 2009;25:683-9.
-
(2009)
Can J Cardiol
, vol.25
, pp. 683-689
-
-
Fitchett, D.1
Eikelboom, J.2
Fremes, S.3
Mazer, D.4
Singh, S.5
Bittira, B.6
-
7
-
-
84882867795
-
Antiplatelet therapy and cardiac surgery: Review of recent evidence and clinical implications
-
23642333
-
Fitchett D, Mazer CD, Eikelboom J, Verma S. Antiplatelet therapy and cardiac surgery: review of recent evidence and clinical implications. Can J Cardiol. 2013;29:1042-7.
-
(2013)
Can J Cardiol
, vol.29
, pp. 1042-1047
-
-
Fitchett, D.1
Mazer, C.D.2
Eikelboom, J.3
Verma, S.4
-
8
-
-
82155173475
-
Use of clopidogrel post-coronary artery bypass surgery in canadian patients with acute coronary syndromes
-
1:CAS:528:DC%2BC38XhtVCmtbbK 21875778
-
Krimly A, Yan RT, Yan AT, DeYoung JP, Gallo R, Steg G, et al. Use of clopidogrel post-coronary artery bypass surgery in canadian patients with acute coronary syndromes. Can J Cardiol. 2011;27:711-5.
-
(2011)
Can J Cardiol
, vol.27
, pp. 711-715
-
-
Krimly, A.1
Yan, R.T.2
Yan, A.T.3
DeYoung, J.P.4
Gallo, R.5
Steg, G.6
-
9
-
-
63449093485
-
Temporal trends and patterns of early clopidogrel use across the spectrum of acute coronary syndromes
-
1:CAS:528:DC%2BD1MXjslyis78%3D 19332190 e641
-
Rao RV, Goodman SG, Yan RT, Spencer FA, Fox KA, DeYoung JP, et al. Temporal trends and patterns of early clopidogrel use across the spectrum of acute coronary syndromes. Am Heart J. 2009;157:642-50. e641.
-
(2009)
Am Heart J
, vol.157
, pp. 642-650
-
-
Rao, R.V.1
Goodman, S.G.2
Yan, R.T.3
Spencer, F.A.4
Fox, K.A.5
DeYoung, J.P.6
-
11
-
-
84864287789
-
Mortality benefit with prasugrel in the TRITON-TIMI 38 coronary artery bypass grafting cohort: Risk-adjusted retrospective data analysis
-
3407327 1:CAS:528:DC%2BC38XhtFajtb3P 22633653
-
Smith PK, Goodnough LT, Levy JH, Poston RS, Short MA, Weerakkody GJ, et al. Mortality benefit with prasugrel in the TRITON-TIMI 38 coronary artery bypass grafting cohort: risk-adjusted retrospective data analysis. J Am Coll Cardiol. 2012;60:388-96.
-
(2012)
J Am Coll Cardiol
, vol.60
, pp. 388-396
-
-
Smith, P.K.1
Goodnough, L.T.2
Levy, J.H.3
Poston, R.S.4
Short, M.A.5
Weerakkody, G.J.6
-
12
-
-
0022992740
-
Meta-analysis in clinical trials
-
1:STN:280:DyaL2s7gsVamtA%3D%3D 3802833
-
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88.
-
(1986)
Control Clin Trials
, vol.7
, pp. 177-188
-
-
DerSimonian, R.1
Laird, N.2
-
15
-
-
78751694614
-
Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery a single-center, randomized, controlled trial
-
1:CAS:528:DC%2BC3cXhs1ansL7O 21050973
-
Gao G, Zheng Z, Pi Y, Lu B, Lu J, Hu S. Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery a single-center, randomized, controlled trial. J Am Coll Cardiol. 2010;56:1639-43.
-
(2010)
J Am Coll Cardiol
, vol.56
, pp. 1639-1643
-
-
Gao, G.1
Zheng, Z.2
Pi, Y.3
Lu, B.4
Lu, J.5
Hu, S.6
-
16
-
-
78650077621
-
Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: The Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting study
-
1:CAS:528:DC%2BC3cXhsFCqsb7K 21146675
-
Sun JC, Teoh KH, Lamy A, Sheth T, Ellins ML, Jung H, et al. Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting study. Am Heart J. 2010;160:1178-84.
-
(2010)
Am Heart J
, vol.160
, pp. 1178-1184
-
-
Sun, J.C.1
Teoh, K.H.2
Lamy, A.3
Sheth, T.4
Ellins, M.L.5
Jung, H.6
-
17
-
-
79551563636
-
Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: Results from the PLATO (Platelet Inhibition and Patient Outcomes) trial
-
1:CAS:528:DC%2BC3MXjtlSnsrc%3D 21194870
-
Held C, Asenblad N, Bassand JP, Becker RC, Cannon CP, Claeys MJ, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. J Am Coll Cardiol. 2011;57:672-84.
-
(2011)
J Am Coll Cardiol
, vol.57
, pp. 672-684
-
-
Held, C.1
Asenblad, N.2
Bassand, J.P.3
Becker, R.C.4
Cannon, C.P.5
Claeys, M.J.6
-
18
-
-
4444338086
-
Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention
-
1:CAS:528:DC%2BD2cXntlenurY%3D 15342293
-
Saw J, Topol EJ, Steinhubl SR, Brennan D, Berger PB, Moliterno DJ, et al. Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention. Am J Cardiol. 2004;94:623-5.
-
(2004)
Am J Cardiol
, vol.94
, pp. 623-625
-
-
Saw, J.1
Topol, E.J.2
Steinhubl, S.R.3
Brennan, D.4
Berger, P.B.5
Moliterno, D.J.6
-
19
-
-
4444229924
-
Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: The Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial
-
1:CAS:528:DC%2BD2cXntFSksL8%3D 15313956
-
Fox KA, Mehta SR, Peters R, Zhao F, Lakkis N, Gersh BJ, et al. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial. Circulation. 2004;110:1202-8.
-
(2004)
Circulation
, vol.110
, pp. 1202-1208
-
-
Fox, K.A.1
Mehta, S.R.2
Peters, R.3
Zhao, F.4
Lakkis, N.5
Gersh, B.J.6
-
20
-
-
0037145863
-
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial
-
1:CAS:528:DC%2BD38XoslOksL0%3D 12435254
-
Steinhubl SR, Berger PB, Mann III JT, Fry ET, DeLago A, Wilmer C, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002;288:2411-20.
-
(2002)
JAMA
, vol.288
, pp. 2411-2420
-
-
Steinhubl, S.R.1
Berger, P.B.2
Mann, J.T.3
Fry, E.T.4
DeLago, A.5
Wilmer, C.6
-
21
-
-
78650701981
-
Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: The clopidogrel after surgery for coronary artery disease (CASCADE) Trial
-
1:CAS:528:DC%2BC3cXhsF2jtbzO 21135365
-
Kulik A, Le May MR, Voisine P, Tardif JC, Delarochelliere R, Naidoo S, et al. Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the clopidogrel after surgery for coronary artery disease (CASCADE) Trial. Circulation. 2010;122:2680-7.
-
(2010)
Circulation
, vol.122
, pp. 2680-2687
-
-
Kulik, A.1
Le May, M.R.2
Voisine, P.3
Tardif, J.C.4
Delarochelliere, R.5
Naidoo, S.6
-
22
-
-
84869174129
-
Aspirin plus clopidogrel for optimal platelet inhibition following off-pump coronary artery bypass surgery: Results from the CRYSSA (prevention of Coronary arteRY bypaSS occlusion after off-pump procedures) randomised study
-
1:CAS:528:DC%2BC3sXktFGquw%3D%3D 22942294
-
Mannacio VA, Di Tommaso L, Antignan A, De Amicis V, Vosa C. Aspirin plus clopidogrel for optimal platelet inhibition following off-pump coronary artery bypass surgery: results from the CRYSSA (prevention of Coronary arteRY bypaSS occlusion After off-pump procedures) randomised study. Heart. 2012;98:1710-5.
-
(2012)
Heart
, vol.98
, pp. 1710-1715
-
-
Mannacio, V.A.1
Di Tommaso, L.2
Antignan, A.3
De Amicis, V.4
Vosa, C.5
-
23
-
-
84899988028
-
Impact of dual antiplatelet therapy on outcomes among aspirin-resistant patients following coronary artery bypass grafting
-
24666617
-
Gasparovic H, Petricevic M, Kopjar T, Djuric Z, Svetina L, Biocina B. Impact of dual antiplatelet therapy on outcomes among aspirin-resistant patients following coronary artery bypass grafting. Am J Cardiol. 2014;113:1660-7.
-
(2014)
Am J Cardiol
, vol.113
, pp. 1660-1667
-
-
Gasparovic, H.1
Petricevic, M.2
Kopjar, T.3
Djuric, Z.4
Svetina, L.5
Biocina, B.6
-
24
-
-
67649819258
-
Clopidogrel and aspirin versus clopidogrel alone on graft patency after coronary artery bypass grafting
-
19559191
-
Gao C, Ren C, Li D, Li L. Clopidogrel and aspirin versus clopidogrel alone on graft patency after coronary artery bypass grafting. Ann Thorac Surg. 2009;88:59-62.
-
(2009)
Ann Thorac Surg
, vol.88
, pp. 59-62
-
-
Gao, C.1
Ren, C.2
Li, D.3
Li, L.4
-
25
-
-
46049099572
-
The role of clopidogrel and acetylsalicylic acid in the prevention of early-phase graft occlusion due to reactive thrombocytosis after coronary artery bypass operation
-
18583285
-
Kayacioglu I, Gunay R, Saskin H, Idiz M, Sensoz Y, Ates M, et al. The role of clopidogrel and acetylsalicylic acid in the prevention of early-phase graft occlusion due to reactive thrombocytosis after coronary artery bypass operation. Heart Surg Forum. 2008;11:E152-157.
-
(2008)
Heart Surg Forum
, vol.11
, pp. E152-157
-
-
Kayacioglu, I.1
Gunay, R.2
Saskin, H.3
Idiz, M.4
Sensoz, Y.5
Ates, M.6
-
26
-
-
70349690638
-
The effect of combined clopidogrel and aspirin therapy after off-pump coronary surgery: A pilot study
-
Mujanovic E, Nurkic M, Caluk J, Terzic I, Kabil E, Bergsland J. The effect of combined clopidogrel and aspirin therapy after off-pump coronary surgery: a pilot study. Innovations (Phila). 2009;4:265-8.
-
(2009)
Innovations (Phila)
, vol.4
, pp. 265-268
-
-
Mujanovic, E.1
Nurkic, M.2
Caluk, J.3
Terzic, I.4
Kabil, E.5
Bergsland, J.6
-
27
-
-
34748825023
-
Hypercoagulability and platelet inhibition after OPCAB. Randomized intervention with clopidogrel
-
1:CAS:528:DC%2BD2sXhtVGrsLfM 17852789
-
Nielsen AB, Bochsen L, Steinbruchel DA. Hypercoagulability and platelet inhibition after OPCAB. Randomized intervention with clopidogrel. Scand Cardiovasc J. 2007;41:325-30.
-
(2007)
Scand Cardiovasc J
, vol.41
, pp. 325-330
-
-
Nielsen, A.B.1
Bochsen, L.2
Steinbruchel, D.A.3
-
28
-
-
84890049579
-
Effect of aspirin plus clopidogrel therapy on aspirin resistance after off-pump coronary artery bypass surgery [Chinese]
-
1:CAS:528:DC%2BC2cXhvVWjt7jJ
-
Wang X-Z, Gong X-X, Zhu T-T, Li C-J, Yang Z-J. Effect of aspirin plus clopidogrel therapy on aspirin resistance after off-pump coronary artery bypass surgery [Chinese]. Acta Acad Med Sinicae. 2013;35:495-502.
-
(2013)
Acta Acad Med Sinicae
, vol.35
, pp. 495-502
-
-
Wang, X.-Z.1
Gong, X.-X.2
Zhu, T.-T.3
Li, C.-J.4
Yang, Z.-J.5
-
29
-
-
84944142977
-
Ticagrelor and Aspirin for the Prevention of Cardiovascular Events after Coronary Artery Bypass Surgery: The TAP-CABG Study
-
Saw JW, Wong G, Mayo J, Bernstein V, Mancini GB, Ye J, et al. Ticagrelor and Aspirin for the Prevention of Cardiovascular Events After Coronary Artery Bypass Surgery: The TAP-CABG Study. J Am Coll Cardiol. 2015;65:A1638.
-
(2015)
J Am Coll Cardiol
, vol.65
, pp. A1638
-
-
Saw, J.W.1
Wong, G.2
Mayo, J.3
Bernstein, V.4
Mancini, G.B.5
Ye, J.6
-
30
-
-
84944039745
-
A study of aspirin plus clopidogrel versus aspirin alone on saphenous vein graft patency after coronary artery bypass graft surgery-an angiographic follow-up after three months
-
Thopte OS, Patil SP, Deshmukh RS. A study of aspirin plus clopidogrel versus aspirin alone on saphenous vein graft patency after coronary artery bypass graft surgery-an angiographic follow-up after three months. Indian Heart Journal. 2014;66:S22.
-
(2014)
Indian Heart Journal
, vol.66
, pp. S22
-
-
Thopte, O.S.1
Patil, S.P.2
Deshmukh, R.S.3
-
31
-
-
84908206651
-
Clopidogrel improves aspirin response after off-pump coronary artery bypass surgery
-
3968281 1:CAS:528:DC%2BC2MXpvVCgsr0%3D 24683408
-
Wang X, Gong X, Zhu T, Zhang Q, Zhang Y, Wang X, et al. Clopidogrel improves aspirin response after off-pump coronary artery bypass surgery. J Biomed Res. 2014;28:108-13.
-
(2014)
J Biomed Res
, vol.28
, pp. 108-113
-
-
Wang, X.1
Gong, X.2
Zhu, T.3
Zhang, Q.4
Zhang, Y.5
Wang, X.6
-
32
-
-
0032728617
-
Antiplatelet activity of clopidogrel in coronary artery bypass graft surgery patients
-
1:CAS:528:DyaK1MXnsVenurs%3D 10595630
-
David JL, Limet R. Antiplatelet activity of clopidogrel in coronary artery bypass graft surgery patients. Thromb Haemost. 1999;82:1417-21.
-
(1999)
Thromb Haemost
, vol.82
, pp. 1417-1421
-
-
David, J.L.1
Limet, R.2
-
33
-
-
4444244344
-
Clopidogrel did not inhibit platelet function early after coronary bypass surgery: A prospective randomized trial
-
1:CAS:528:DC%2BD2cXosFyksbc%3D 15354104
-
Lim E, Cornelissen J, Routledge T, Kirtland S, Charman SC, Bellm S, et al. Clopidogrel did not inhibit platelet function early after coronary bypass surgery: A prospective randomized trial. J Thorac Cardiovasc Surg. 2004;128:432-5.
-
(2004)
J Thorac Cardiovasc Surg
, vol.128
, pp. 432-435
-
-
Lim, E.1
Cornelissen, J.2
Routledge, T.3
Kirtland, S.4
Charman, S.C.5
Bellm, S.6
-
34
-
-
84944051533
-
Aspirin versus clopidogrel after off-pump coronary artery bypass grafting: Prospective, randomized head-to-head trial
-
Los Angeles;
-
Suwalski G., Smoczycski R., Banach M., Gryszko L., Szaaacski P., Krawczyk K., Hendzel P., Aspirin versus clopidogrel after off-pump coronary artery bypass grafting: Prospective, randomized head-to-head trial. 15th Annual Meeting of the International Society for Minimally Invasive Cardiothoracic Surgery. 2012, 7, 138 Los Angeles;
-
(2012)
15th Annual Meeting of the International Society for Minimally Invasive Cardiothoracic Surgery.
, vol.7
, pp. 138
-
-
Suwalski, G.1
Smoczycski, R.2
Banach, M.3
Gryszko, L.4
Szaaacski, P.5
Krawczyk, K.6
Hendzel, P.7
-
35
-
-
77949894173
-
Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: A prospective randomized study
-
1:CAS:528:DC%2BC3cXltFCrtro%3D 19703819
-
Tetik S, Ak K, Isbir S, Eksioglu-Demiralp E, Arsan S, Iqbal O, et al. Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study. Clin Appl Thromb Hemost. 2010;16:189-98.
-
(2010)
Clin Appl Thromb Hemost
, vol.16
, pp. 189-198
-
-
Tetik, S.1
Ak, K.2
Isbir, S.3
Eksioglu-Demiralp, E.4
Arsan, S.5
Iqbal, O.6
-
36
-
-
33645552037
-
Biological efficacy of low against medium dose aspirin regimen after coronary surgery: Analysis of platelet function
-
1:CAS:528:DC%2BD28XjtVOgsLY%3D 16525576
-
Cornelissen J, Kirtland S, Lim E, Goddard M, Bellm S, Sheridan K, et al. Biological efficacy of low against medium dose aspirin regimen after coronary surgery: analysis of platelet function. Thromb Haemost. 2006;95:476-82.
-
(2006)
Thromb Haemost
, vol.95
, pp. 476-482
-
-
Cornelissen, J.1
Kirtland, S.2
Lim, E.3
Goddard, M.4
Bellm, S.5
Sheridan, K.6
-
37
-
-
33745241394
-
Biological efficacy of low versus medium dose aspirin after coronary surgery: Results from a randomized trial [NCT00262275]
-
1479833 16716214
-
Lim E, Cornelissen J, Routledge T, Ali A, Kirtland S, Sharples L, et al. Biological efficacy of low versus medium dose aspirin after coronary surgery: results from a randomized trial [NCT00262275]. BMC Med. 2006;4:12.
-
(2006)
BMC Med
, vol.4
, pp. 12
-
-
Lim, E.1
Cornelissen, J.2
Routledge, T.3
Ali, A.4
Kirtland, S.5
Sharples, L.6
-
38
-
-
33645861080
-
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
-
1:CAS:528:DC%2BD28Xjs12gsLk%3D 16531616
-
Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006;354:1706-17.
-
(2006)
N Engl J Med
, vol.354
, pp. 1706-1717
-
-
Bhatt, D.L.1
Fox, K.A.2
Hacke, W.3
Berger, P.B.4
Black, H.R.5
Boden, W.E.6
-
39
-
-
35548995394
-
Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: Primary results of the DISPERSE-2 trial
-
1:CAS:528:DC%2BD2sXht1GlurzI 17980250
-
Cannon CP, Husted S, Harrington RA, Scirica BM, Emanuelsson H, Peters G, et al. Safety, tolerability, and initial efficacy of AZD6140, the first reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 trial. J Am Coll Cardiol. 2007;50:1844-51.
-
(2007)
J Am Coll Cardiol
, vol.50
, pp. 1844-1851
-
-
Cannon, C.P.1
Husted, S.2
Harrington, R.A.3
Scirica, B.M.4
Emanuelsson, H.5
Peters, G.6
-
40
-
-
27644548513
-
Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: Randomised placebo-controlled trial
-
1:STN:280:DC%2BD2MrptlKmtQ%3D%3D 16271642
-
Chen ZM, Jiang LX, Chen YP, Xie JX, Pan HC, Peto R, et al. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet. 2005;366:1607-21.
-
(2005)
Lancet
, vol.366
, pp. 1607-1621
-
-
Chen, Z.M.1
Jiang, L.X.2
Chen, Y.P.3
Xie, J.X.4
Pan, H.C.5
Peto, R.6
-
41
-
-
84867177857
-
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization
-
1:CAS:528:DC%2BC38XhsFWksL3K 22920930
-
Roe MT, Armstrong PW, Fox KA, White HD, Prabhakaran D, Goodman SG, et al. Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. N Engl J Med. 2012;367:1297-309.
-
(2012)
N Engl J Med
, vol.367
, pp. 1297-1309
-
-
Roe, M.T.1
Armstrong, P.W.2
Fox, K.A.3
White, H.D.4
Prabhakaran, D.5
Goodman, S.G.6
-
42
-
-
21644448736
-
Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: Results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 trial
-
1:CAS:528:DC%2BD2MXlsVyjs7g%3D 15967851
-
Wiviott SD, Antman EM, Winters KJ, Weerakkody G, Murphy SA, Behounek BD, et al. Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 trial. Circulation. 2005;111:3366-73.
-
(2005)
Circulation
, vol.111
, pp. 3366-3373
-
-
Wiviott, S.D.1
Antman, E.M.2
Winters, K.J.3
Weerakkody, G.4
Murphy, S.A.5
Behounek, B.D.6
-
43
-
-
34848862447
-
Benefits and risks of clopidogrel pretreatment before coronary artery bypass grafting in patients with ST-elevation myocardial infarction treated with fibrinolytics in CLARITY-TIMI 28
-
1:CAS:528:DC%2BD2sXosFKrt70%3D 17323134
-
McLean DS, Sabatine MS, Guo W, McCabe CH, Cannon CP. Benefits and risks of clopidogrel pretreatment before coronary artery bypass grafting in patients with ST-elevation myocardial infarction treated with fibrinolytics in CLARITY-TIMI 28. J Thromb Thrombolysis. 2007;24:85-91.
-
(2007)
J Thromb Thrombolysis
, vol.24
, pp. 85-91
-
-
McLean, D.S.1
Sabatine, M.S.2
Guo, W.3
McCabe, C.H.4
Cannon, C.P.5
-
44
-
-
77956290748
-
Dose comparisons of clopidogrel and aspirin in acute coronary syndromes
-
20818903
-
Mehta SR, Bassand JP, Chrolavicius S, Diaz R, Eikelboom JW, Fox KA, et al. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. N Engl J Med. 2010;363:930-42.
-
(2010)
N Engl J Med
, vol.363
, pp. 930-942
-
-
Mehta, S.R.1
Bassand, J.P.2
Chrolavicius, S.3
Diaz, R.4
Eikelboom, J.W.5
Fox, K.A.6
-
45
-
-
0035936484
-
Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery
-
1:CAS:528:DC%2BD3MXhtF2ksLw%3D 11157686
-
Bhatt DL, Chew DP, Hirsch AT, Ringleb PA, Hacke W, Topol EJ. Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery. Circulation. 2001;103:363-8.
-
(2001)
Circulation
, vol.103
, pp. 363-368
-
-
Bhatt, D.L.1
Chew, D.P.2
Hirsch, A.T.3
Ringleb, P.A.4
Hacke, W.5
Topol, E.J.6
-
46
-
-
84883807129
-
Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: Insights from the PLATelet inhibition and patient outcomes (PLATO) trial
-
1:CAS:528:DC%2BC3sXhtFygur7N 24016496
-
Brilakis ES, Held C, Meier B, Cools F, Claeys MJ, Cornel JH, et al. Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: insights from the PLATelet inhibition and patient outcomes (PLATO) trial. Am Heart J. 2013;166:474-80.
-
(2013)
Am Heart J
, vol.166
, pp. 474-480
-
-
Brilakis, E.S.1
Held, C.2
Meier, B.3
Cools, F.4
Claeys, M.J.5
Cornel, J.H.6
-
47
-
-
84896532727
-
Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: Subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome)
-
1:CAS:528:DC%2BC2cXksFaiurw%3D 24211500
-
Whellan DJ, Tricoci P, Chen E, Huang Z, Leibowitz D, Vranckx P, et al. Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome). J Am Coll Cardiol. 2014;63:1048-57.
-
(2014)
J Am Coll Cardiol
, vol.63
, pp. 1048-1057
-
-
Whellan, D.J.1
Tricoci, P.2
Chen, E.3
Huang, Z.4
Leibowitz, D.5
Vranckx, P.6
-
48
-
-
84869439940
-
Thrombelastographic haemostatic status and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial): Assessing and monitoring the antithrombotic effect of clopidogrel and aspirin versus aspirin alone in hypercoagulable patients: Study protocol for a randomized controlled trial
-
3502390 1:CAS:528:DC%2BC3sXhvF2ntbw%3D 22540524
-
Rafiq S, Johansson PI, Zacho M, Stissing T, Kofoed K, Lilleor NB, et al. Thrombelastographic haemostatic status and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial): assessing and monitoring the antithrombotic effect of clopidogrel and aspirin versus aspirin alone in hypercoagulable patients: study protocol for a randomized controlled trial. Trials. 2012;13:48.
-
(2012)
Trials
, vol.13
, pp. 48
-
-
Rafiq, S.1
Johansson, P.I.2
Zacho, M.3
Stissing, T.4
Kofoed, K.5
Lilleor, N.B.6
-
49
-
-
84944059113
-
-
Eli Lilly and Company, Sankyo D. Effient (Prasugrel) Acute Coronary Syndromes Managed by Percutaneous Coronary Intervention. 2009.http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/CardiovascularandRenalDrugsAdvisoryCommittee/ucm129219.pdf
-
(2009)
Acute Coronary Syndromes Managed by Percutaneous Coronary Intervention
-
-
-
50
-
-
84875213860
-
Transfusion outcomes in patients undergoing coronary artery bypass grafting treated with prasugrel or clopidogrel: TRITON-TIMI 38 retrospective data analysis
-
4151878 22995726 e1074
-
Goodnough LT, Smith PK, Levy JH, Poston RS, Short MA, Weerakkody GJ, et al. Transfusion outcomes in patients undergoing coronary artery bypass grafting treated with prasugrel or clopidogrel: TRITON-TIMI 38 retrospective data analysis. J Thorac Cardiovasc Surg. 2013;145:1077-82. e1074.
-
(2013)
J Thorac Cardiovasc Surg
, vol.145
, pp. 1077-1082
-
-
Goodnough, L.T.1
Smith, P.K.2
Levy, J.H.3
Poston, R.S.4
Short, M.A.5
Weerakkody, G.J.6
-
51
-
-
79959550517
-
Standardized bleeding definitions for cardiovascular clinical trials: A consensus report from the Bleeding Academic Research Consortium
-
21670242
-
Mehran R, Rao SV, Bhatt DL, Gibson CM, Caixeta A, Eikelboom J, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation. 2011;123:2736-47.
-
(2011)
Circulation
, vol.123
, pp. 2736-2747
-
-
Mehran, R.1
Rao, S.V.2
Bhatt, D.L.3
Gibson, C.M.4
Caixeta, A.5
Eikelboom, J.6
-
52
-
-
73949112820
-
Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: The ONSET/OFFSET study
-
1:CAS:528:DC%2BD1MXhsFGgtb3N 19923168
-
Gurbel PA, Bliden KP, Butler K, Tantry US, Gesheff T, Wei C, et al. Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study. Circulation. 2009;120:2577-85.
-
(2009)
Circulation
, vol.120
, pp. 2577-2585
-
-
Gurbel, P.A.1
Bliden, K.P.2
Butler, K.3
Tantry, U.S.4
Gesheff, T.5
Wei, C.6
-
53
-
-
84895522368
-
Ticagrelor increases adenosine plasma concentration in patients with an acute coronary syndrome
-
1:CAS:528:DC%2BC2cXjsVKksbw%3D 24291273
-
Bonello L, Laine M, Kipson N, Mancini J, Helal O, Fromonot J, et al. Ticagrelor increases adenosine plasma concentration in patients with an acute coronary syndrome. J Am Coll Cardiol. 2014;63:872-7.
-
(2014)
J Am Coll Cardiol
, vol.63
, pp. 872-877
-
-
Bonello, L.1
Laine, M.2
Kipson, N.3
Mancini, J.4
Helal, O.5
Fromonot, J.6
-
54
-
-
84885663662
-
Clopidogrel is safer than ticagrelor in regard to bleeds: A closer look at the PLATO trial
-
23907035
-
DiNicolantonio JJ, D'Ascenzo F, Tomek A, Chatterjee S, Niazi AK, Biondi-Zoccai G. Clopidogrel is safer than ticagrelor in regard to bleeds: a closer look at the PLATO trial. Int J Cardiol. 2013;168:1739-44.
-
(2013)
Int J Cardiol
, vol.168
, pp. 1739-1744
-
-
DiNicolantonio, J.J.1
D'Ascenzo, F.2
Tomek, A.3
Chatterjee, S.4
Niazi, A.K.5
Biondi-Zoccai, G.6
-
55
-
-
84868648318
-
Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: A substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trial
-
22991347
-
Husted S, James S, Becker RC, Horrow J, Katus H, Storey RF, et al. Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trial. Circ Cardiovasc Qual Outcomes. 2012;5:680-8.
-
(2012)
Circ Cardiovasc Qual Outcomes
, vol.5
, pp. 680-688
-
-
Husted, S.1
James, S.2
Becker, R.C.3
Horrow, J.4
Katus, H.5
Storey, R.F.6
-
56
-
-
84875124713
-
Dual anti-platelet therapy after coronary artery bypass grafting: Is there any benefit? A systematic review and meta-analysis
-
23488578
-
Deo SV, Dunlay SM, Shah IK, Altarabsheh SE, Erwin PJ, Boilson BA, et al. Dual anti-platelet therapy after coronary artery bypass grafting: is there any benefit? A systematic review and meta-analysis. J Card Surg. 2013;28:109-16.
-
(2013)
J Card Surg
, vol.28
, pp. 109-116
-
-
Deo, S.V.1
Dunlay, S.M.2
Shah, I.K.3
Altarabsheh, S.E.4
Erwin, P.J.5
Boilson, B.A.6
-
57
-
-
84887018422
-
Meta-analysis of effect of single versus dual antiplatelet therapy on early patency of bypass conduits after coronary artery bypass grafting
-
24035160
-
Nocerino AG, Achenbach S, Taylor AJ. Meta-analysis of effect of single versus dual antiplatelet therapy on early patency of bypass conduits after coronary artery bypass grafting. Am J Cardiol. 2013;112:1576-9.
-
(2013)
Am J Cardiol
, vol.112
, pp. 1576-1579
-
-
Nocerino, A.G.1
Achenbach, S.2
Taylor, A.J.3
-
58
-
-
84908159334
-
Effectiveness and Safety of Dual Anti-platelet Therapy after Coronary Artery Bypass Grafting: A Meta-Analysis [Chinese]
-
Li JH, Aikeremu MT, Zhang MM, Yilihamu A. Effectiveness and Safety of Dual Anti-platelet Therapy after Coronary Artery Bypass Grafting: A Meta-Analysis [Chinese]. Chin J Evid-based Med. 2014;14:958-65.
-
(2014)
Chin J Evid-based Med
, vol.14
, pp. 958-965
-
-
Li, J.H.1
Aikeremu, M.T.2
Zhang, M.M.3
Yilihamu, A.4
-
59
-
-
84860995253
-
Use of aspirin and clopidogrel after coronary artery bypass graft surgery
-
22570427
-
de Leon N, Jackevicius CA. Use of aspirin and clopidogrel after coronary artery bypass graft surgery. Ann Pharmacother. 2012;46:678-87.
-
(2012)
Ann Pharmacother
, vol.46
, pp. 678-687
-
-
De Leon, N.1
Jackevicius, C.A.2
-
61
-
-
67649395606
-
Evidence for using clopidogrel alone or in addition to aspirin in post coronary artery bypass surgery patients
-
1:CAS:528:DC%2BD1MXnsV2rsro%3D 19539077
-
Patel JH, Stoner JA, Owora A, Mathew ST, Thadani U. Evidence for using clopidogrel alone or in addition to aspirin in post coronary artery bypass surgery patients. Am J Cardiol. 2009;103:1687-93.
-
(2009)
Am J Cardiol
, vol.103
, pp. 1687-1693
-
-
Patel, J.H.1
Stoner, J.A.2
Owora, A.3
Mathew, S.T.4
Thadani, U.5
-
62
-
-
79960555699
-
Adjusted indirect comparison meta-analysis of prasugrel versus ticagrelor for patients with acute coronary syndromes
-
20828843
-
Biondi-Zoccai G, Lotrionte M, Agostoni P, Abbate A, Romagnoli E, Sangiorgi G, et al. Adjusted indirect comparison meta-analysis of prasugrel versus ticagrelor for patients with acute coronary syndromes. Int J Cardiol. 2011;150:325-31.
-
(2011)
Int J Cardiol
, vol.150
, pp. 325-331
-
-
Biondi-Zoccai, G.1
Lotrionte, M.2
Agostoni, P.3
Abbate, A.4
Romagnoli, E.5
Sangiorgi, G.6
-
63
-
-
84884820847
-
Comparing newer oral anti-platelets prasugrel and ticagrelor in reduction of ischemic events-evidence from a network meta-analysis
-
1:CAS:528:DC%2BC3sXhsVOltb%2FJ 23212803
-
Chatterjee S, Ghose A, Sharma A, Guha G, Mukherjee D, Frankel R. Comparing newer oral anti-platelets prasugrel and ticagrelor in reduction of ischemic events-evidence from a network meta-analysis. J Thromb Thrombolysis. 2013;36:223-32.
-
(2013)
J Thromb Thrombolysis
, vol.36
, pp. 223-232
-
-
Chatterjee, S.1
Ghose, A.2
Sharma, A.3
Guha, G.4
Mukherjee, D.5
Frankel, R.6
-
64
-
-
84920006727
-
Should clopidogrel be discontinued before coronary artery bypass grafting for patients with acute coronary syndrome? A systematic review and meta-analysis
-
1:CAS:528:DC%2BC2cXhtVanurnO 24954178
-
Cao C, Indraratna P, Ang SC, Manganas C, Park J, Bannon PG, et al. Should clopidogrel be discontinued before coronary artery bypass grafting for patients with acute coronary syndrome? A systematic review and meta-analysis. J Thorac Cardiovasc Surg. 2014;148(6):3092-8.
-
(2014)
J Thorac Cardiovasc Surg
, vol.148
, Issue.6
, pp. 3092-3098
-
-
Cao, C.1
Indraratna, P.2
Ang, S.C.3
Manganas, C.4
Park, J.5
Bannon, P.G.6
-
65
-
-
84455205618
-
Preoperative thienopyridine use and outcomes after surgery: A systematic review
-
22079019 e81
-
Au AG, Majumdar SR, McAlister FA. Preoperative thienopyridine use and outcomes after surgery: a systematic review. Am J Med. 2012;125:87-99. e81.
-
(2012)
Am J Med
, vol.125
, pp. 87-99
-
-
Au, A.G.1
Majumdar, S.R.2
McAlister, F.A.3
-
66
-
-
84857440263
-
Benefits and risks of using clopidogrel before coronary artery bypass surgery: Systematic review and meta-analysis of randomized trials and observational studies
-
1:CAS:528:DC%2BC38XisFSgs7Y%3D 21703636 e664
-
Biancari F, Airaksinen KE, Lip GY. Benefits and risks of using clopidogrel before coronary artery bypass surgery: systematic review and meta-analysis of randomized trials and observational studies. J Thorac Cardiovasc Surg. 2012;143:665-75. e664.
-
(2012)
J Thorac Cardiovasc Surg
, vol.143
, pp. 665-675
-
-
Biancari, F.1
Airaksinen, K.E.2
Lip, G.Y.3
-
67
-
-
84892599355
-
Continuing antiplatelet therapy before cardiac surgery with cardiopulmonary bypass: A meta-analysis on the need for reexploration and major outcomes
-
23972983
-
Guay J, Andrew Ochroch E. Continuing antiplatelet therapy before cardiac surgery with cardiopulmonary bypass: a meta-analysis on the need for reexploration and major outcomes. J Cardiothorac Vasc Anesth. 2014;28:90-7.
-
(2014)
J Cardiothorac Vasc Anesth
, vol.28
, pp. 90-97
-
-
Guay, J.1
Andrew Ochroch, E.2
-
68
-
-
84940300591
-
Impact of perioperative use of clopidogrel on coronary bypass grafting patients: A meta-analysis
-
Ma J, Xu W-J, Xu G-P. Impact of perioperative use of clopidogrel on coronary bypass grafting patients: a meta-analysis. Chin J Evid-Based Med. 2013;13:827-35.
-
(2013)
Chin J Evid-Based Med
, vol.13
, pp. 827-835
-
-
Ma, J.1
Xu, W.-J.2
Xu, G.-P.3
-
69
-
-
82455201598
-
Safety of clopidogrel being continued until the time of coronary artery bypass grafting in patients with acute coronary syndrome: A meta-analysis of 34 studies
-
1:CAS:528:DC%2BC3MXhsFygu77O 21609973
-
Nijjer SS, Watson G, Athanasiou T, Malik IS. Safety of clopidogrel being continued until the time of coronary artery bypass grafting in patients with acute coronary syndrome: a meta-analysis of 34 studies. Eur Heart J. 2011;32:2970-88.
-
(2011)
Eur Heart J
, vol.32
, pp. 2970-2988
-
-
Nijjer, S.S.1
Watson, G.2
Athanasiou, T.3
Malik, I.S.4
-
70
-
-
33645243978
-
Does clopidogrel affect outcome after coronary artery bypass grafting? A meta-analysis
-
1860879 1:CAS:528:DC%2BD28XjslOkt7s%3D 16537769
-
Purkayastha S, Athanasiou T, Malinovski V, Tekkis P, Foale R, Casula R, et al. Does clopidogrel affect outcome after coronary artery bypass grafting? A meta-analysis. Heart. 2006;92:531-2.
-
(2006)
Heart
, vol.92
, pp. 531-532
-
-
Purkayastha, S.1
Athanasiou, T.2
Malinovski, V.3
Tekkis, P.4
Foale, R.5
Casula, R.6
-
71
-
-
84864364080
-
Network meta-analysis of prasugrel, ticagrelor, high- and standard-dose clopidogrel in patients scheduled for percutaneous coronary interventions
-
1:CAS:528:DC%2BC38Xht1GitbjP 22627948
-
Steiner S, Moertl D, Chen L, Coyle D, Wells GA. Network meta-analysis of prasugrel, ticagrelor, high- and standard-dose clopidogrel in patients scheduled for percutaneous coronary interventions. Thromb Haemost. 2012;108:318-27.
-
(2012)
Thromb Haemost
, vol.108
, pp. 318-327
-
-
Steiner, S.1
Moertl, D.2
Chen, L.3
Coyle, D.4
Wells, G.A.5
-
72
-
-
27844438752
-
Does clopidogrel improve the long-term outcome after coronary artery bypass surgery?
-
16146975
-
Biancari F, Juvonen T. Does clopidogrel improve the long-term outcome after coronary artery bypass surgery? Scand Cardiovasc J. 2005;39:135-6.
-
(2005)
Scand Cardiovasc J
, vol.39
, pp. 135-136
-
-
Biancari, F.1
Juvonen, T.2
-
73
-
-
79957514069
-
How to explain the reduced cardiovascular mortality in the ticagrelor arm of the PLATO trial?
-
21406313
-
De Servi S, Savonitto S. How to explain the reduced cardiovascular mortality in the ticagrelor arm of the PLATO trial? Int J Cardiol. 2011;149:265-7.
-
(2011)
Int J Cardiol
, vol.149
, pp. 265-267
-
-
De Servi, S.1
Savonitto, S.2
-
74
-
-
78649708659
-
Antiplatelet therapy and coronary artery bypass graft surgery a fallow land
-
21126641
-
Montalescot G, Hulot JS, Collet JP. Antiplatelet therapy and coronary artery bypass graft surgery a fallow land. J Am Coll Cardiol. 2010;56:2003-5.
-
(2010)
J Am Coll Cardiol
, vol.56
, pp. 2003-2005
-
-
Montalescot, G.1
Hulot, J.S.2
Collet, J.P.3
-
75
-
-
11144338258
-
Impact of clopidogrel in coronary artery bypass grafting
-
15621501
-
Shrivastava V, Akowuah E. Impact of clopidogrel in coronary artery bypass grafting. Eur J Cardiothorac Surg. 2005;27:176-7.
-
(2005)
Eur J Cardiothorac Surg
, vol.27
, pp. 176-177
-
-
Shrivastava, V.1
Akowuah, E.2
-
76
-
-
0035949960
-
Clopidogrel versus aspirin after cardiac surgery
-
1:STN:280:DC%2BD3MrisFCqsA%3D%3D 11571262
-
Verheugt FW. Clopidogrel versus aspirin after cardiac surgery. Circulation. 2001;104:E76.
-
(2001)
Circulation
, vol.104
, pp. E76
-
-
Verheugt, F.W.1
-
77
-
-
31044441345
-
Postoperative clopidogrel improves mid-term outcome after off-pump coronary artery bypass graft surgery: A prospective study
-
Gurbuz AT, Zia AA, Vuran AC, Cui H, Aytac A. Postoperative clopidogrel improves mid-term outcome after off-pump coronary artery bypass graft surgery: a prospective study. Eur J Cardio-thorac Surg. 2006;29:190-5.
-
(2006)
Eur J Cardio-thorac Surg
, vol.29
, pp. 190-195
-
-
Gurbuz, A.T.1
Zia, A.A.2
Vuran, A.C.3
Cui, H.4
Aytac, A.5
-
78
-
-
33846060154
-
Effect of clopidogrel on midterm graft patency following off-pump coronary revascularization surgery
-
17060036
-
Ibrahim K, Tjomsland O, Halvorsen D, Wiseth R, Wahba A, Karevold A, et al. Effect of clopidogrel on midterm graft patency following off-pump coronary revascularization surgery. Heart Surg Forum. 2006;9:E581-856.
-
(2006)
Heart Surg Forum
, vol.9
, pp. E581-856
-
-
Ibrahim, K.1
Tjomsland, O.2
Halvorsen, D.3
Wiseth, R.4
Wahba, A.5
Karevold, A.6
|